SME Central
Home / SME Stocks / Jfl Life Sciences

Jfl Life Sciences: IPO, Share Price and Results Since Listing

For H2 FY2026 it reported revenue of INR 63.05 crore (+91.15% on a year earlier) and a profit after tax of INR 1.66 crore.

Key Facts

Listed on NSE Emerge
8 September 2022
Symbol
JFLLIFE
Latest close
INR 13.50 on 11 November 2026
Lot size now
6,000 shares (INR 81,000 at the latest close)

Results Filed With NSE

Standalone figures, INR crore. Change compares with the same period a year earlier.

PeriodRevenueChangeProfit after taxEPS (INR)Filed
Q2 FY202798.65+229.85%5.131.28after listing2 November 2026
Q1 FY202711.10-4.17%1.110.34after listing10 August 2026
H2 FY202663.05+91.15%1.660.50after listing29 May 2026
FY2026131.38+60.14%6.401.94after listing29 May 2026
Q3 FY202626.84–2.020.61after listing29 January 2026
Q2 FY202629.91–1.980.60after listing11 November 2025
Q1 FY202611.59–0.750.23after listing11 August 2025
H2 FY202532.99–0.800.24after listing28 June 2025
FY202582.04–4.161.26after listing28 June 2025
Q4 FY202511.73–0.080.03after listing21 May 2025

Promoter Holding

Promoter holding has moved from 67.47% on 31 December 2022 to 67.47% on 30 September 2026 (0 percentage points).

As ofPromotersPublic
30 September 202667.47%32.53%
30 June 202667.47%32.53%
31 March 202667.47%32.53%
31 December 202567.47%32.53%
30 September 202567.47%32.53%
30 June 202567.47%32.53%
10 June 202567.47%32.53%
31 March 202567.47%32.53%
30 September 202467.47%32.53%
31 March 202467.47%32.53%
30 September 202367.47%32.53%
31 March 202367.47%32.54%
31 December 202267.47%32.53%

Sources: NSE Emerge filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.